<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000633081"><TermName>AdreView</TermName><TermPronunciation>(A-dreh-VYOO)</TermPronunciation><TermDefinition><DefinitionText>A drug containing a form of radioactive iodine called I 123 that is used to detect certain types of tumors, including pheochromocytomas and neuroblastomas. Radiation from the I 123 may help show where cancer cells are in the body. AdreView is a type of radioimaging agent and a type of radioconjugate. Also called 123I-MIBG, iobenguane I 123,  and iodine I 123 metaiodobenzylguanidine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722612" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;AdreView&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722611" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;AdreView&quot;" language="es" id="_4"/><SpanishTermName>AdreView</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que contiene una forma de yodo radiactivo que se llama I 123. Se usa para detectar ciertos tipos de tumores, como los feocromocitomas y los neuroblastomas. La radiación del I 123 puede ayudar a identificar los lugares del cuerpo donde hay células cancerosas. AdreView es un tipo de sustancia para radioimaginología y un tipo de radioconjugado. También se llama 123I-MIBG, iobenguano I 123,  y yodo I 123 metayodobenzilguanidina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-04-24</DateFirstPublished><DateLastModified>2012-11-01</DateLastModified></GlossaryTerm>
